Longview Acquisition Corp. II
Status: Liquidated
U=S+W/5
W=S@11.5
| IPO Proceeds, $M | $690.00M |
|---|---|
| IPO Date | Mar 19, 2021 |
| CEO | John Rodin |
| Left Lead | UBS |
| IPO Cash in Trust | 100.0% |
| SPAC Tenor | 24 months |
| IPO Sector | Healthcare ▶ |
| IPO Geography | Global |
| Target Company | N/A |
| Deal Announced | N/A |
| Deal Size, $M | TBD |
| Deal Sector | TBD |
| Deal Geography | TBD |
| SEC Filings |
www.sec.gov 
|
| Approval Vote | TBD |
| Amendment Vote | Dec 14, 2022 |
| Closing Date | Dec 21, 2022 |
LGV
LGV.U
LGV/W
| Price | |
|---|---|
| Volume, 3-month avg. | N/A |
Sign up for Free Trial
No credit card required
Sign in to view structure, cap table, and calendar of events.